Work Group Listing

  1. WG11 ePrescribing & Related Transactions

    Work Group 11 ePrescribing & Related Transactions develops standardized messages for prescribers, pharmacists, payers and/or other interested parties to exchange information related to a prescribing event or patient encounter.

  2. WG14 Long Term Post Acute Care (LTPAC)

    Work Group 14 Long Term and Post Acute Care (LTPAC), in conjunction with the other Work Groups, guides and advises payers, processors, and providers of the long-term care industry and institutional pharmacy programs and their agents on standards implementation and supports data processing initiatives.

  3. WG16 Property and Casualty/Workers' Compensation

    Work Group 16 Property and Casualty/Workers' Compensation will ascertain, monitor and analyze regulatory requirements to develop and recommend correlating fields to be supported in the Telecommunication Standard format; evaluate, and maintain a Property and Casualty/Workers’ Compensation standard paper claim form; proactively promote and educate pharmacy industry stakeholders and regulatory policy makers on the form and format standards found in Property and Casualty/Workers’ Compensation. This includes but is not limited to uniform billing, state reporting policies and the overall delivery of pharmacy services/care.

  4. WG18 Specialty Pharmacy

    Develops, monitors and maintains existing and new standards and guidance for the electronic exchange of data amongst providers, pharmacies, manufacturers, payers/processors and other stakeholders to facilitate patient access to specialty products and related business processes.

    The work group, in conjunction with other NCPDP Work Groups, guides and advises stakeholders on standards implementation and supports data processing initiatives.  The work group may request modifications to other NCPDP standards as necessary.

  5. WG45 External Standards Assessment, Harmonization and Implementation Guidance

    Work Group 45 External Standards Assessment, Harmonization and Implementation Guidance reviews, assesses and works to continually monitor the development of standards and/or operating rules by other Standards Development Organizations (SDOs) and/or other Non-NCPDP entities that may impact the pharmacy industry. The Work Group

    • Communicates SDO and other external entities’ developments and identifies actions that may be needed by this or other NCPDP work groups. These include, but are not limited to, X12 Incorporated Implementation Guides, Health Level Seven International (HL7®) Standards, and International Committee for Information Technology Standards (INCITS).    
    •  
    • Develops and maintains guidelines for the pharmacy industry to accommodate pharmacy implementation of the Health Insurance Portability and Accountability Act (HIPAA) and Affordable Care Act (ACA) mandated electronic data interchange (EDI) transactions and operating rules not developed by NCPDP as determined by the membership.
    •  
    • Contributes to the development and maintenance of operating rules that impact the pharmacy industry.
    To this end, Work Group 45 External Standards Assessment, Harmonization and Implementation Guidance will collaborate with other SDOs, operating rules entities or other Non-NCPDP entities to provide the pharmacy perspective and represent the industry needs in the development of standards and guidelines.

WG2 Product Identification Goals

    1. Promote NCPDP membership attendance and active participation in work group meetings and task groups.
    2. Continue to maintain and enhance the Billing Unit Standard (BUS) Implementation Guide for NCPDP members and other impacted parties (such as government agencies, manufacturers).
    3. Encourage attendance and participation by pharmaceutical manufacturers to address resolution of billing issues before product launch. 
    4. Collaborate with other work groups to facilitate mutual goal achievement:
      1. WG1 Telecommunication to maintain consistent product identifiers and facilitate interoperability between product identifiers used throughout the Telecommunication Standard.
      2. WG7 Manufacturer and Associated Trading Partner Transaction Standards to increase cooperation between NCPDP and the Centers for Medicare and Medicaid Services (CMS).
      3. WG11 ePrescribing and Related Transactions to maintain consistent product identifiers and facilitate drug database consistency.
      4. WG 18- Specialty Pharmacy to assist in facilitating patient access to specialty products
      5. MC Maintenance and Control to support MC Education-Legislation and Regulation Task Group when new legislation is introduced regarding issues relevant to the work group.
    5. Review and adjudicate Quantity Unit Information Communication (QUIC) Forms.
    6. Monitor and report on issues relating to the scope of WG2 including but not limited to National Committee on Vital and Health Statistics (NCVHS), Food and Drug Administration (FDA), Health Level Seven International (HL7®), National Library of Medicine’s (NLM) RxNorm, and bar code activity.
    7. Continue collaboration with American Society of Health-System Pharmacists (ASHP), FDA, NCVHS, CMS, NLM, United States Pharmacopeial Convention (USP), United States Adopted Names Council (USAN) and HL7®.
    8. Continue to provide clarification and education on the structure of the National Drug Code (NDC), Universal Product Code (UPC), Unique Device Identifier (UDI) and the National Health Related Item Code (HRI) as they are formatted for use within the NCPDP standards. Monitor and participate in the development of new identifiers and provide input on standards conformance when appropriate.
    9. Provide input to the FDA on their continued development of the enhancement to the Structured Product Labeling (SPL) and ongoing guidance to support the use of the Billing Unit Standard (BUS) within the SPL.
    10. Determine and apply the BUS to new products and to existing products that have had labeling changes.
    11. Review and modify, where appropriate, billing unit exceptions within the BUS.
    12. Monitor WG2 task groups to ensure they are tracking scope, goals, and deliverables. Disband task groups that have completed their work.
    13. Maintain and formulate frequently asked questions (FAQs) for the Product Identifier Standard to provide guidance on how they are used in dispensing, purchasing, administration, medical records, reimbursement, etc. within the industry.
    14. Review Data Element Request Forms (DERFs) and adjudicate ballots pertaining to standards for which this work group is responsible.
    15. Analyze, develop and execute Webinar opportunities for WG2 standards in coordination with Educational Programs Advisors Group.
    For a list of acronyms, please see the Acronym Dictionary

WG2 Product Identification Scope

  • Work Group 2 Product Identification deals with issues relating to the identification of drugs and health related products within NCPDP’s stated mission. Identification consists of how the product is billed (billing units,package size  designations), product identification systems, and any type of descriptive data which serves to uniquely identify a product with the intent to establish standards for product identification such that there is no ambiguity in distinguishing one product from another.

1 2 3

For problems with the site please contact us at webmaster@ncpdp.org